The Integrase: An Overview of a Key Player Enzyme in the Antiviral Scenario

Int J Mol Sci. 2023 Jul 29;24(15):12187. doi: 10.3390/ijms241512187.

Abstract

Integration of a desossiribonucleic acid (DNA) copy of the viral ribonucleic acid (RNA) into host genomes is a fundamental step in the replication cycle of all retroviruses. The highly conserved virus-encoded Integrase enzyme (IN; EC 2.7.7.49) catalyzes such a process by means of two consecutive reactions named 3'-processing (3-P) and strand transfer (ST). The Authors report and discuss the major discoveries and advances which mainly contributed to the development of Human Immunodeficiency Virus (HIV) -IN targeted inhibitors for therapeutic applications. All the knowledge accumulated over the years continues to serve as a valuable resource for the design and development of effective antiretroviral drugs.

Keywords: 3′-processing; IN-strand transfer inhibitors (INSTIs); allosteric IN inhibitors (ALLINIs); dual inhibitors; integrase (IN) enzyme; multimeric INIs (MINIs); strand transfer inhibitors.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • HIV Integrase Inhibitors* / pharmacology
  • HIV-1*
  • Humans
  • Integrases

Substances

  • Antiviral Agents
  • Integrases
  • HIV Integrase Inhibitors

Grants and funding

This research received no external funding.